Thyroid lobectomy is not sufficient for T2 papillary thyroid cancers

被引:43
作者
Rajjoub, Samer R. [1 ]
Yan, Huan [1 ]
Calcatera, Natalie A. [1 ]
Kuchta, Kristine [1 ]
Wang, Chi-Hsiung E. [1 ]
Lutfi, Waseem [1 ]
Moo-Young, Tricia A. [1 ]
Winchester, David J. [1 ]
Prinz, Richard A. [1 ]
机构
[1] Northshore Univ HealthSyst, Dept Surg, Evanston, IL USA
关键词
FOLLICULAR VARIANT; CARCINOMA; SURVIVAL; EXTENT; SURGERY; INDEX;
D O I
10.1016/j.surg.2017.12.026
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Histologic subtypes of papillary thyroid cancer affect prognosis. The objective of this study was to examine whether survival is affected by extent of surgery for conventional versus follicular-variant papillary thyroid cancer when stratified by tumor size. Methods: Using the National Cancer Data Base, we evaluated 33,816 adults undergoing surgery for papillary thyroid cancer from 2004 to 2008 for 1.0-3.9 cm tumors and clinically negative lymph nodes. Conventional and follicular-variant papillary thyroid cancers were divided into separate groups. Cox regression models stratified by tumor size were used to determine if extent of surgery affected overall survival. Results: A total of 30,981 patients had total thyroidectomy and 2,835 had thyroid lobectomy; 22,899 patients had conventional papillary thyroid cancer and 10,918 had follicular-variant papillary thyroid cancer. On unadjusted KM analysis, total thyroidectomy was associated with improved survival for conventional (P = 0.02) but not for follicular-variant papillary thyroid cancer patients (P = 0.42). For conventional papillary thyroid cancer, adjusted analysis showed total thyroidectomy was associated with improved survival for 2.0-3.9 cm tumors (P = 0.03) but not for 1.0-1.9 cm tumors (P = 0.16). For follicular-variant, lobectomy and total thyroidectomy had equivalent survival for 1.0-1.9 cm (P = 0.45) and 2.0-3.9 cm (P = 0.88) tumors. Conclusion: Tumor size, histologic subtype, and surgical therapy are important factors in papillary thyroid cancer survival. Total thyroidectomy was associated with improved survival in patients with 2.0-3.9 cm conventional papillary thyroid cancer, and should be considered for 2.0-3.9 cm papillary thyroid cancers when preoperative molecular analysis is not used to distinguish conventional from follicular-variant. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:1134 / 1143
页数:10
相关论文
共 28 条
  • [1] Extent of Surgery for Papillary Thyroid Cancer Is Not Associated With Survival An Analysis of 61,775 Patients
    Adam, Mohamed Abdelgadir
    Pura, John
    Gu, Lin
    Dinan, Michaela A.
    Tyler, Douglas S.
    Reed, Shelby D.
    Scheri, Randall
    Roman, Sanziana A.
    Sosa, Julie A.
    [J]. ANNALS OF SURGERY, 2014, 260 (04) : 601 - 607
  • [2] [Anonymous], 2016, CANC FACTS FIG 2015
  • [3] Extent of surgery affects survival for papillary thyroid cancer
    Bilimoria, Karl Y.
    Bentrem, David J.
    Ko, Clifford Y.
    Stewart, Andrew K.
    Winchester, David P.
    Talamonti, Mark S.
    Sturgeon, Cord
    [J]. ANNALS OF SURGERY, 2007, 246 (03) : 375 - 384
  • [4] Black WC, 2002, JNCI-J NATL CANCER I, V94, P167, DOI 10.1093/jnci/94.3.167
  • [5] CARCANGIU ML, 1985, CANCER-AM CANCER SOC, V55, P805, DOI 10.1002/1097-0142(19850215)55:4<805::AID-CNCR2820550419>3.0.CO
  • [6] 2-Z
  • [7] Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
    Cooper, David S.
    Doherty, Gerard M.
    Haugen, Bryan R.
    Kloos, Richard T.
    Lee, Stephanie L.
    Mandel, Susan J.
    Mazzaferri, Ernest L.
    McIver, Bryan
    Pacini, Furio
    Schlumberger, Martin
    Sherman, Steven I.
    Steward, David L.
    Tuttle, R. Michael
    [J]. THYROID, 2009, 19 (11) : 1167 - 1214
  • [8] NATURAL-HISTORY, TREATMENT, AND COURSE OF PAPILLARY THYROID-CARCINOMA
    DEGROOT, LJ
    KAPLAN, EL
    MCCORMICK, M
    STRAUS, FH
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (02) : 414 - 424
  • [9] ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES
    DEYO, RA
    CHERKIN, DC
    CIOL, MA
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) : 613 - 619
  • [10] 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
    Haugen, Bryan R.
    Alexander, Erik K.
    Bible, Keith C.
    Doherty, Gerard M.
    Mandel, Susan J.
    Nikiforov, Yuri E.
    Pacini, Furio
    Randolph, Gregory W.
    Sawka, Anna M.
    Schlumberger, Martin
    Schuff, Kathryn G.
    Sherman, Steven I.
    Sosa, Julie Ann
    Steward, David L.
    Tuttle, R. Michael
    Wartofsky, Leonard
    [J]. THYROID, 2016, 26 (01) : 1 - 133